Congenital ichthyosiform erythroderma
Congenital ichthyosiform erythroderma (CIE) is a rare genetic disorder that primarily affects the skin. It is a type of ichthyosis, a group of genetic skin disorders characterized by dry, thickened, scaly or flaky skin. CIE is present at birth and continues throughout the individual's life.
Symptoms
The main symptom of CIE is red, scaly skin. The scaling can be fine or thick and is usually most severe on the extremities (arms and legs), but can also affect the torso and face. Other symptoms can include ectropion, which is an outward turning of the eyelid, and alopecia, or hair loss.
Causes
CIE is caused by mutations in several different genes. These genes are involved in the formation and function of the skin's stratum corneum, the outermost layer of the skin. When these genes are mutated, the stratum corneum does not form properly, leading to the symptoms of CIE.
Diagnosis
Diagnosis of CIE is based on the characteristic skin abnormalities present at birth or shortly thereafter. A skin biopsy may be performed to confirm the diagnosis. Genetic testing can also be done to identify the specific gene mutation causing the condition.
Treatment
There is no cure for CIE, but treatments can help manage the symptoms. These may include emollients to moisturize the skin, keratolytics to help remove scales, and retinoids to reduce the production of skin cells. In severe cases, hospitalization may be required.
Prognosis
The prognosis for individuals with CIE varies. Some individuals may have a normal lifespan with few complications, while others may experience severe symptoms and complications that can affect their quality of life and lifespan.
See also

This article is a genetic disorder stub. You can help WikiMD by expanding it!
This article is a skin-condition stub. You can help WikiMD by expanding it!
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian